China Just Unleashed a Massive Policy to Dominate the Global Brain-Computer Interface (BCI) Race

Key Points

  • China’s government, via seven powerful ministries, released a major policy on August 7, 2025, to make the country a world leader in Brain-Computer Interface (BCI) technology.
  • The policy outlines ambitious goals: by 2027, achieve breakthroughs in core BCI technologies, chips, and devices; by 2030, cultivate 2-3 globally influential BCI companies and significant innovation capabilities.
  • The initiative targets both implantable and non-invasive BCI devices, focusing on high-density neural recording, ultra-low-power chips, and practical applications in healthcare and consumer products.
  • The market reacted positively, with A-share BCI-related stocks, including Chuangxin Medical (创新医疗) and Jihua Group (际华集团), surging on the news.
  • The global BCI market is projected to reach $7 billion by 2030, while the Chinese BCI market, valued at ¥1.73 billion RMB ($240.5 million USD) in 2023, is projected to exceed ¥120 billion RMB ($16.7 billion USD) by 2040.
Decorative Image

China’s brain-computer interface (BCI) industry just got a massive shot of adrenaline, and if you’re an investor, founder, or just a tech nerd, you need to pay attention.

On August 7, 2025, seven of the country’s most powerful ministries jointly dropped a bombshell policy document designed to supercharge the nation’s BCI development.

The “Implementation Opinions on Promoting the Innovative Development of the Brain-Computer Interface Industry” isn’t just another government paper.

It’s a clear, aggressive, and well-funded roadmap to make China a world leader in one of the most futuristic technologies on the planet.

Let’s break down what this means.

The 7-Ministry Playbook for BCI Supremacy

This wasn’t a minor announcement.

The policy was co-signed by a powerhouse lineup of government bodies:

  • Ministry of Industry and Information Technology
  • National Development and Reform Commission
  • Ministry of Education
  • National Health Commission
  • State-owned Assets Supervision and Administration Commission
  • Chinese Academy of Sciences
  • National Medical Products Administration

Their joint “Opinions” lay out 17 specific measures to fast-track the BCI industry.

The goals are ambitious and time-bound.

The Roadmap: China’s BCI Goals to 2030

Here’s the game plan, straight up:

By 2027, the goal is to:

  • Achieve major breakthroughs in core BCI technologies, including key chips and algorithms.
  • Establish a robust technical, industrial, and safety standard system.
  • Push the performance of electrodes, chips, and complete BCI devices to internationally advanced levels.
  • Accelerate the real-world application of BCI products in manufacturing, healthcare, and daily consumer life.

And looking further to 2030:

  • Dramatically improve the BCI industry’s overall innovation capabilities.
  • Cultivate 2 to 3 globally influential BCI companies and a whole ecosystem of “specialized, refined, distinctive, and innovative” small and medium-sized enterprises (SMEs).
  • Build an internationally competitive industrial ecosystem that puts China’s comprehensive BCI strength among the world’s leaders.

Key Milestones for China’s BCI Development
YearKey Goals
2027Breakthroughs in core BCI technologies (chips, algorithms); Establish technical, industrial, and safety standards; International-level performance for electrodes, chips, and devices; Accelerated real-world application.
2030Improved innovation capabilities; Cultivate 2-3 globally influential BCI companies and thriving SMEs; Achieve leading global BCI strength.
Resume Captain Logo

Resume Captain

Your AI Career Toolkit:

  • AI Resume Optimization
  • Custom Cover Letters
  • LinkedIn Profile Boost
  • Interview Question Prep
  • Salary Negotiation Agent
Get Started Free
Decorative Image

Inside the Tech: What China is Actually Building

So, how are they going to do it? The policy gets surprisingly specific about the tech they’re targeting.

Pushing the Limits on Implantable & Non-Invasive Devices

The focus is on both ends of the BCI spectrum:

  • Implantable BCI: They’re chasing next-gen products that integrate high-density neural recording sensors with ultra-low-power implantable chips. The aim is better brain intention recognition, faster response speeds, and higher control accuracy.
  • Mature Medical Tech: The plan includes improving existing, proven devices like deep brain stimulators and cochlear implants to enhance their efficacy.
  • <

  • Non-Invasive BCI: Get ready for mass production and iteration of devices like forehead patches, ear patches, in-ear devices, and even hair-clip BCI. The push is to make these products lightweight, high-speed, and incredibly power-efficient.

The Race for a “Brain Chip” Breakthrough

Chips are the heart of any BCI system, and China is laser-focused on developing its own.

  • Signal Acquisition Chips: Developing high-channel, high-speed chips to better acquire and amplify faint brain signals while suppressing noise.
  • Signal Processing Chips: Researching high-performance, ultra-low-power chips for parallel processing to integrate perception, computation, and regulation functions.
  • Communication Chips: Building ultra-low-power, high-speed, and highly reliable communication chips to ensure brain signal transmission is fast and interference-free.

Don’t Forget the Auxiliary Gear

It’s not just about the brain. The policy also calls for:

  • Multi-modal Devices: Creating auxiliary devices that integrate brain signals with other physiological signals like electromyography (muscle), electrooculography (eye), and electrocardiography (heart) to improve control accuracy.
  • Surgical Robots: Developing high-precision surgical robots for implanting BCI devices, with a focus on sub-micron level precision and real-time 3D imaging.

Decorative Image

The Market Reaction: Stocks Surged on the News

The market didn’t wait to react.

Following the announcement, A-share BCI-related stocks collectively jumped in late trading on August 7th.

  • Chuangxin Medical (Chuangxin Yiliao 创新医疗) and Jihua Group (Jihua Jituan 际华集团) both hit their daily upward limit.
  • Beiyikang (Beiyikang 倍益康) surged over 17%.
  • Xiangyu Medical (Xiangyu Yiliao 翔宇医疗) rose over 11%.
  • Aipeng Medical (Aipeng Yiliao 爱朋医疗) and Weisi Medical (Weisi Yiliao 伟思医疗) also saw significant gains.

Securities firms are already telling clients that the BCI industry is entering a period of rapid development with vast potential.

Selected BCI Related Stock Performance (August 7th)
Company NamePerformance
Chuangxin Medical (创新医疗)Daily upward limit
Jihua Group (际华集团)Daily upward limit
Beiyikang (倍益康)Surged over 17%
Xiangyu Medical (翔宇医疗)Rose over 11%
Aipeng Medical (爱朋医疗)Significant gains
Weisi Medical (伟思医疗)Significant gains
TeamedUp China Logo

Find Top Talent on China's Leading Networks

  • Post Across China's Job Sites from $299 / role, or
  • Hire Our Recruiting Pros from $799 / role
  • - - - - - - - -
  • Qualified Candidate Bundles
  • Lower Hiring Costs by 80%+
  • Expert Team Since 2014
Get 25% Off
Your First Job Post
Decorative Image

It’s Not Just Policy: The Whole BCI Ecosystem is Leveling Up

This government push is happening alongside major moves in the private and healthcare sectors.

Apple’s BCI Ambitions & China’s Role

It’s been reported that Apple (Pingguo 苹果) is already collaborating with BCI companies to create standards for “manipulating Apple devices using brain signals.”

A recent demo video showed a patient with amyotrophic lateral sclerosis (ALS) successfully controlling an iPad with their thoughts via a BCI device. This is the kind of tangible progress that moves a market.

Healthcare Paves the Way for Commercialization

This might be the most underrated part of the story. China’s National Healthcare Security Administration (NHSA) has already created a pathway for BCI to become a profitable medical procedure.

They’ve established new pricing items like:

  • “brain-computer interface implantation fees”
  • “brain-computer interface adaptation fees”

This is a massive deal. It means once BCI tech is approved for clinical use, hospitals can immediately start offering it and billing for it, creating a clear path to revenue.

ExpatInvest China Logo

ExpatInvest China

Grow Your RMB in China:

  • Invest Your RMB Locally
  • Buy & Sell Online in CN¥
  • No Lock-In Periods
  • English Service & Data
  • Start with Only ¥1,000
View Funds & Invest
Decorative Image

The Multi-Billion Dollar Opportunity: BCI Market by the Numbers

The market projections for BCI are staggering, and China is positioned to capture a huge piece of the pie.

Here’s what the analysts are saying:

  • According to Dongwu Securities (Dongwu Zhengquan 东吴证券), the global BCI market is projected to hit around $7 billion USD by 2030, growing at a 16.4% CAGR.
  • China’s domestic BCI market is already growing fast, reaching ¥1.73 billion RMB ($240.5 million USD) in 2023.
  • The big number comes from McKinsey, which projects the Chinese BCI market could exceed ¥120 billion RMB ($16.7 billion USD) by 2040, with an insane compound annual growth rate of 26%.

BCI Market Projections (Global vs. China)
MarketYearProjected ValueCAGR
Global BCI Market2030$7 Billion USD16.4%
China BCI Market2023¥1.73 Billion RMB ($240.5 Million USD)N/A
China BCI Market2040>¥120 Billion RMB ($16.7 Billion USD)26%
Decorative Image

The Takeaway: China is Going All-In on BCI

The message from Beijing is loud and clear: China is determined to be a dominant force in the brain-computer interface revolution.

With massive government support, a clear technological roadmap, a ready-to-go healthcare commercialization path, and a rapidly growing market, the stage is set for explosive growth.

For anyone in tech, investing, or building the future, China’s brain-computer interface sector is no longer just a ‘what if’—it’s a ‘right now’.

References

In this article
Scroll to Top